Stocks Explorer
Stocks
Sectors
Search
Cytokinetics, Incorporated(CYTK) News
Profile
Chart
News
Analysis
Holders
CYTK price today
by TradingView
Date
Title
Jun 20
Cytokinetics Announces Start of MAPLE-HCM, a Phase 3 Clinical Trial of Aficamten Compared to Metoprolol in Patients With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Apr 27
Cytokinetics (CYTK) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
‹ Prev
Page
of 6
Next ›